Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03561376 · ClinicalTrials.gov registry record · Early Phase 1
Zinc Oxide Versus Petrolatum Following Skin Surgery
A Early Phase 1 study of Surgical Site Infection and Surgical Wound, sponsored by Melissa Pugliano-Mauro.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03561376 is a Early Phase 1 study of Surgical Site Infection and Surgical Wound that is actively recruiting participants, run by Melissa Pugliano-Mauro. The registered enrollment target is 30 participants, below the 567-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03561376, a Early Phase 1 study of Surgical Site Infection and Surgical Wound, is actively recruiting participants, sponsored by Melissa Pugliano-Mauro.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing routine surgery in the Department of Dermatology for any indication on non-scalp skin and closed in linear fashion with scar greater than or equal to 4.5cm in length will be invited to participate in this split scar, head to head study comparing zinc oxide and petrolatum. Patients will apply respective ointments to each half of scar daily for one month and maintain a log of these activities. They will be seen at 1 week, 4 weeks, 8 weeks, and 6 months post-operatively for photographic scar assessment and to complete the patient portion of the Patient and Observer Scar Assessment Scale (POSAS), a quantitative objective assessment of scar appearance. Trained observers (board-certified dermatologists) will score the observer portion of the scale. POSAS outcomes, post-operative infections, linear density of epidermal seal will be assessed at the 1 week, 4 weeks, 8 weeks, and 6 months post-operative periods and compared between the two groups. Participants will have parking validated for all visits and upon completion of all portions of the study will receive a standardized skin care gift bag containing samples for hypoallergenic skin care products (washes, moisturizers, etc.).
Conditions Studied
Interventions
- DRUG Topical zinc oxide vs. petrolatum post-surgical scars
Study Locations (1)
Pennsylvania
- UPMC Dermatology St. Margaret - Pittsburgh, PA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-10-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03561376
The ClinicalTrials.gov registry entry for NCT03561376 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 567-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (95% lower). The listed sponsor is Melissa Pugliano-Mauro, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Surgical Site Infection appearing as the primary indexed condition, and to 1 intervention - of which Topical zinc oxide vs. petrolatum post-surgical scars is the first listed.
NCT03561376 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03561376 about?
NCT03561376 is a clinical study titled "Zinc Oxide Versus Petrolatum Following Skin Surgery". Patients undergoing routine surgery in the Department of Dermatology for any indication on non-scalp skin and closed in linear fashion with scar greater than or equal to 4.5cm in length will be invited to participate in this split scar, head to head study comparing zinc oxide and petrolatum. Patient...
What is the current status of trial NCT03561376?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2021-09-01. Estimated completion is 2026-10-30.
What conditions does trial NCT03561376 study?
This clinical trial studies the following conditions: Surgical Site Infection, Surgical Wound, Scar, Surgery--Complications, Hypertrophic Scar.
What interventions are being tested in trial NCT03561376?
The interventions under investigation include: Topical zinc oxide vs. petrolatum post-surgical scars (DRUG).
Who is sponsoring clinical trial NCT03561376?
This trial is sponsored by Melissa Pugliano-Mauro, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03561376 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
RECRUITING · Phase 3
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
RECRUITING · NA
-
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
RECRUITING · Phase 4
-
Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.